These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8891054

  • 1. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.
    Gómez-Tortosa E, del Barrio A, Jiménez-Alfaro I.
    Acta Neurol Scand; 1996 Aug; 94(2):104-9. PubMed ID: 8891054
    [Abstract] [Full Text] [Related]

  • 2. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease.
    Arai H, Terajima M, Nakagawa T, Higuchi S, Mochizuki H, Sasaki H.
    Neuroreport; 1996 Mar 22; 7(4):918-20. PubMed ID: 8724673
    [Abstract] [Full Text] [Related]

  • 3. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y.
    Neurobiol Aging; 2003 Oct 22; 24(6):789-96. PubMed ID: 12927761
    [Abstract] [Full Text] [Related]

  • 4. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
    Higuchi S, Matsushita S, Hasegawa Y, Muramatsu T, Arai H.
    Exp Neurol; 1997 Mar 22; 144(1):199-201. PubMed ID: 9126171
    [Abstract] [Full Text] [Related]

  • 5. [Experience with pupil tropicamide test in Alzheimer's disease].
    Robles A, Touriño R, Sesar A, Suárez P, Noya M.
    Rev Neurol; 1996 Jan 22; 24(125):65-8. PubMed ID: 8852002
    [Abstract] [Full Text] [Related]

  • 6. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?
    Kurz A, Marquard R, Fremke S, Leipert KP.
    Pharmacopsychiatry; 1997 Jan 22; 30(1):12-5. PubMed ID: 9065964
    [Abstract] [Full Text] [Related]

  • 7. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J, Linzmayer L, Walter H, Rainer M, Masching A, Pezawas L, Saletu-Zyhlarz G, Stöhr H, Grünberger M.
    Neuropsychobiology; 1999 Jan 22; 40(1):40-6. PubMed ID: 10420100
    [Abstract] [Full Text] [Related]

  • 8. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
    Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B.
    Int J Psychophysiol; 2003 Feb 22; 47(2):95-115. PubMed ID: 12568941
    [Abstract] [Full Text] [Related]

  • 9. The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease.
    Reitner A, Baumgartner I, Thuile C, Baradaran Dilmaghani R, Ergun E, Kaminski S, Lukas J, Dal Bianco P.
    Vision Res; 1997 Jan 22; 37(1):165-8. PubMed ID: 9068838
    [Abstract] [Full Text] [Related]

  • 10. Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.
    Hou RH, Samuels ER, Raisi M, Langley RW, Szabadi E, Bradshaw CM.
    Psychopharmacology (Berl); 2006 Jan 22; 184(1):95-106. PubMed ID: 16308726
    [Abstract] [Full Text] [Related]

  • 11. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.
    Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC.
    Mayo Clin Proc; 1997 Jun 22; 72(6):495-504. PubMed ID: 9179132
    [Abstract] [Full Text] [Related]

  • 12. The pupillary response to tropicamide in Alzheimer's disease.
    Fridh M, Havelius U, Elofsson G, Hindfelt B.
    Acta Ophthalmol Scand; 1996 Jun 22; 74(3):276-9. PubMed ID: 8828726
    [Abstract] [Full Text] [Related]

  • 13. Pupillary response to tropicamide in patients with Alzheimer disease.
    Loupe DN, Newman NJ, Green RC, Lynn MJ, WIlliams KK, Geis TC, Edelhauser HF.
    Ophthalmology; 1996 Mar 22; 103(3):495-503. PubMed ID: 8600428
    [Abstract] [Full Text] [Related]

  • 14. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A, Touriño R, Gude F, Noya M.
    Funct Neurol; 1999 Mar 22; 14(4):203-7. PubMed ID: 10713893
    [Abstract] [Full Text] [Related]

  • 15. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.
    FitzSimon JS, Waring SC, Kokmen E, McLaren JW, Brubaker RF.
    Arch Neurol; 1997 Feb 22; 54(2):155-9. PubMed ID: 9041856
    [Abstract] [Full Text] [Related]

  • 16. ApoE allelic variability influences pupil response to cholinergic challenge and cognitive impairment.
    Scinto LF.
    Genes Brain Behav; 2007 Apr 22; 6(3):209-15. PubMed ID: 16764677
    [Abstract] [Full Text] [Related]

  • 17. [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].
    Kono K, Miyao M, Ishihara S, Takagi A, Ikari H, Suzuki Y, Iguchi A.
    Nihon Ronen Igakkai Zasshi; 1996 Nov 22; 33(11):829-34. PubMed ID: 8997102
    [Abstract] [Full Text] [Related]

  • 18. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
    Kálmán J, Kanka A, Maglóczky E, Szóke A, Járdánházy T, Janka Z.
    Biol Psychiatry; 1997 Apr 15; 41(8):909-11. PubMed ID: 9099419
    [No Abstract] [Full Text] [Related]

  • 19. Pupillary response to topical tropicamide as a marker for Alzheimer's disease.
    Treloar AJ, Assin M, Macdonald AJ.
    Br J Clin Pharmacol; 1996 Mar 15; 41(3):256-7. PubMed ID: 8866930
    [Abstract] [Full Text] [Related]

  • 20. Is videopupillography useful in the diagnosis of Alzheimer's disease?
    Ferrario E, Molaschi M, Villa L, Varetto O, Bogetto C, Nuzzi R.
    Neurology; 1998 Mar 15; 50(3):642-4. PubMed ID: 9521249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.